ProjectIVAC-ALL-1
Basic data
Title:
IVAC-ALL-1
Duration:
01/10/2016 to 31/12/2018
Abstract / short description:
Prospective phase I/II study: Patient-individualized peptide vaccination based on whole exome sequencing with adjuvant GM-CSF in children with relapsed acute lymphoblastic leukemia
Keywords:
adjuvant GM-CSF
children
Kinder
leukemia
Leukämie
peptide vaccination
relapsed acute lymphoblastic leukemia
patient-individualized
Involved staff
Managers
Faculty of Medicine
University of Tübingen
University of Tübingen
Contact persons
Faculty of Medicine
University of Tübingen
University of Tübingen
Local organizational units
University Children’s Hospital - Department of Paediatrics
Hospitals and clinical institutes
Faculty of Medicine
Faculty of Medicine
Funders
Heidelberg, Baden-Württemberg, Germany